Consulting Services
We serve as the bridge between what patients want and what companies need.
We are a strategic consultancy firm focused on Patient Engagement, and Health Literacy, and Empowerly, our communication platform.
Our clear, inclusive communication becomes a catalyst to building trust between organizations like yours and the diverse communities you aim to serve.

Strategic Consulting
This approach provides you with a customized consulting service that enables you to work directly with one or more of our Legacy leaders to think strategically about the future of Patient Engagement for your organization. With experts who specialize in Patient Engagement, Health Literacy, C-Suite, Genetics Counseling and more, we collaborate with you to infuse the patient voice in your organization.

What is it? A customized approach to our client’s needs with recommendations and collaborative conversations.
What problem does it address? Many biopharma and med-tech companies see other companies moving forward with patient engagement activities, but they do not know how to get started. Or, companies may be conducting some activities sporadically, and they want to understand how to do more. In both cases, companies are eager to learn from the learn from subject matter experts in this niche and rapidly evolving field.
What is our approach? Optimizing the benefits of patient perspectives in research and development has many potential paths that need to be prioritized and tailored to the strategic priorities, challenges, and culture of an organization. We believe customized solutions must build on the knowledge and expertise of internal stakeholders at a project or program team level, R&D, and corporate. We provide consultation to understand the unique needs of our clients including their current state and desired future state for incorporating patient perspectives, and combining this analysis with our deep experience in the Patient Engagement landscape to develop a strategic plan, progress individual tactics whether they be developing Board or investor relationship materials or Patient advisory councils to co-create medical products.
What results do we see? Increased understanding of the current state and desired future state of Patient Engagement across the organization for leaders at all levels and critical insights as to key prioritized areas across the organization where Patient Engagement may specifically help address challenges or further enhance efforts. The result is tailor-made approaches that help companies navigate better outcomes and value for those they serve faster.


Patient Engagement Plan
The Patient Engagement Plan is an 8-week collaborative process we deliver that results in a strategic roadmap for how, when, and why your team will engage with patients and care partners in the development of new medical products.
Planning and prioritizing upfront allows you to optimize opportunities, budget appropriately, and maximize insights for key internal and external (regulatory and payer) decision- making to best support the development and delivery of new products for patients.
What is it? A refined and effective process to bring internal cross-functional teams together to develop a roadmap specifically focused on optimizing patient engagement opportunities for a given asset from R&D into commercialization, resulting in a Plan that can be incorporated into an asset’s overall strategy.
What problem does it address? Many companies see opportunities to bring insights from patients living with a given condition to inform decisions on endpoint selection, informed consent language, adequacy of Patient-Reported Outcome measure in assessing what really matters to patients only weeks before the need arises. This is too late. Quality Patient Engagement requires planning to help ensure the right patient voices are represented, with various elements of diversity, whether geographic, age, sexual orientation, race/ethnicity, or stage of disease, for example. Planning and prioritizing when, why, and how insights from patients will be obtained allow for optimizing opportunities, budgeting, and maximizing insights for key internal and external decision-making (regulatory and payer) to best support clinical development and evidence generation.
What is our approach? We form a core team with key leaders of a program or project team, and complete pre-work using existing source documents (e.g. asset strategy, Target Product Profile). A date for the 3-hour Patient Engagement Plan Workshop mid-way through the six-to-eight-week process. This facilitated and highly interactive cross-function Workshop, live or virtual, focuses on the information the internal team needs to understand from patients or the patient community, by when, and for what purpose. The Workshop output is compiled and analyzed together with Legacy’s deep experience and understanding of the Patient Engagement landscape. Final outputs are discussed with the internal core and full team, and the plan is then integrated into the asset strategy.
What results do we see? Many leaders and team members within organizations have concerns that “keep them up at night regarding what patients really need.” Often, they realize their teams may be making assumptions about patient perspectives. By bringing internal stakeholders together, we find that these concerns are not only validated across team members but concerted efforts to ensure patients’ voice as brought into the process of development is truly desired and needed and through the Patient Engagement Plan process and resulting plan, teams now have an effective methodology and plan to address the issues that will help leaders feel confident that the products they are development will truly meet the needs of patients.

Patient Insights Workshop
Our Patient Insights Workshop provides relevant patient insights directly from those living with a condition to share their uniquely valuable perspective to inform the work you are doing.
We work with you to understand your objectives and bring representative views to inform your decision.



Community Awareness and Engagement Program
The Community Awareness and Engagement Program is developed in partnership with biopharmaceutical or med-tech companies to increase awareness, education, and activation for a given condition or treatment. Programs can be tailored to reach specific and traditionally underrepresented communities.
What is it? A program developed in partnership with a biopharmaceutical or med-tech company to increase awareness or education around a given condition is often intended for a hard-to-reach community and one where a “hero” from that community can help attract and engage individuals to learn.
What problem does it address? Underrepresented communities are often left behind, facing worse outcomes when receiving care for health or opportunities to participate in some of the most advanced medicine offered in clinical trials. In addition, many people are turning to social health online for answers to their health concerns and are provided support, resources, and information that they might find valuable to inform their health care decision through traditional routes such as their health care providers.
What is our approach? We create programs that meet our clients’ needs and engage communities around a “hero” to bring increased awareness, education, resources, and inspire hope. Activities can be virtual or in-person and are designed to reach people where they are, to empower people in their health care journey, and to help them feel less alone. At the same time, these communities may gain from more specific outputs of an engagement that benefits both the community and our clients.
What results do we see? The results of community awareness and engagement programs are the shared benefit we can deliver for our clients and the gratefulness our clients receive from community members that helps build trust, reputation, and better outcomes for both companies and the patients they serve.
Why Forward-Thinking Biopharma and Med-tech Companies Work With Us
We speak industry, and we speak patient. Our leadership team has decades of experience building programs that lead to better patient outcomes, lower costs, and more profound program learnings. We are already up to speed on what works well and how it affects your R&D process.